Pfizer COVID-19 Vaccine Rollout
South Africa to Receive 20 Million Doses of the Pfizer COVID-19 Vaccine
Image sourced from TimesLIVE Pfizer is set to distribute 20 million doses of its COVID-19 Vaccine to South Africa – starting mid-April. This comes after the pharmaceutical company managed to resolve contractual conditions that weren’t in line with South Africa’s normal procurement policies, revealed Department of Health deputy director-general, Anban Pillay. According to Bloomberg, the Pfizer-BioNTech version will be “used to kick-start the rollout after a decision not to use AstraZeneca Plc’s shot, which was found to offer little protection against mild forms of COVID-19 in a local trial”. AstraZeneca Vaccine Only ‘Minimally Effective’ Against South African COVID-19 Variant, says Researcher The AstraZeneca COVID-19 vaccine has proven ‘minimally effective’ against the South African variant...
Pfizer COVID-19 Vaccine Proven ‘Less Effective’ Against South African Virus
Image sourced from TimesLIVE A lab study by Pfizer and BioNTech has shown that its COVID-19 vaccine has proven ‘less effective’ against the South African variant by producing “lower levels of neutralizing antibodies”. According to Bloomberg, the results are “part of tests of its vaccine against a lab-created virus that had all the mutations found in the South African variant, which is thought to spread faster than earlier versions”. “The mutant virus has become a stumbling block for vaccine campaigns, with South Africa halting the rollout of AstraZeneca Plc’s shot after a study showed it didn’t work as well in preventing mild illness involving the variant first identified there”. The AstraZeneca COVID-19 vaccine – of which South Africa has received one million doses – has proven ‘minimally...
